Systemic treatment of vitreous inflammation

John B. Christoforidis, Susie Chang, Angela Jiang, Jillian Wang, Colleen M. Cebulla

Research output: Contribution to journalReview articlepeer-review

2 Scopus citations

Abstract

Non infectious vitreous inflammation is often vision threatening and can be associated with potentially life-threatening systemic conditions. Treatment is often challenging as it involves systemic medications that can be associated with adverse effects. The classes of drugs are ever expanding and include corticosteroids, antimetabolites, alkylating agents, T-cell and calcineurin agents, biologic agents, and interferons. Each class of systemic therapy for non-infectious vitreous inflammation is reviewed. We discuss the mechanisms of action, usual clinical dosages, the specific conditions that are treated, the adverse effects, and usual course of treatment for each class of therapy.

Original languageEnglish (US)
Article number936721
JournalMediators of Inflammation
Volume2012
DOIs
StatePublished - 2012

ASJC Scopus subject areas

  • Immunology
  • Cell Biology

Fingerprint Dive into the research topics of 'Systemic treatment of vitreous inflammation'. Together they form a unique fingerprint.

Cite this